title: [How I manage respiratory syncytial virus, human herpesvirus 6 and adenovirus reactivation or infection after allogeneic stem cell transplantation: a report of the SFGM-TC].
abstract: In the attempt to harmonize clinical practices between different French transplantation centers, the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC) set up the third annual series of workshops which brought together practitioners from all member centers and took place in October 2012 in Lille. Here we report our results and recommendations regarding the management of virus respiratory syncytial virus (RSV), human herpes virus 6 (HHV6) or adenovirus allogeneic Stem Cell Transplantation.
authors.affiliation: Service d'hématologie, hôpital Jean-Minjoz, CHU de Besançon, 2, boulevard Fleming, 25030 Besançon, France.
authors.forename: E
authors.initials: E
authors.lastname: Deconinck
authors.forename: J-H
authors.initials: JH
authors.lastname: Dalle
authors.forename: A
authors.initials: A
authors.lastname: Berceanu
authors.forename: P
authors.initials: P
authors.lastname: Chevallier
authors.forename: R
authors.initials: R
authors.lastname: Duléry
authors.forename: A
authors.initials: A
authors.lastname: Garnier
authors.forename: A
authors.initials: A
authors.lastname: Huynh
authors.forename: H
authors.initials: H
authors.lastname: Labussière-Wallet
authors.forename: S
authors.initials: S
authors.lastname: Nguyen Quoc
authors.forename: A
authors.initials: A
authors.lastname: Dewilde
authors.forename: P
authors.initials: P
authors.lastname: Ramon
authors.forename: I
authors.initials: I
authors.lastname: Yakoub-Agha
mesh_terms: D000256:Adenoviridae / Q000502:physiology; D000257:Adenoviridae Infections / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D032921:Consensus; D046148:Donor Selection / Q000592:standards; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects* / Q000592:standards / Q000706:statistics & numerical data; D015654:Herpesvirus 6, Human / Q000502:physiology; D006801:Humans; D007165:Immunosuppression Therapy / Q000592:standards / Q000706:statistics & numerical data; D018357:Respiratory Syncytial Virus Infections / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D012136:Respiratory Syncytial Viruses / Q000502:physiology; D019349:Roseolovirus Infections / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D014184:Transplantation, Homologous; D014775:Virus Activation / Q000502:physiology*
keywords: Adenovirus; Adénovirus; Allogeneic SCT; Allogreffe de CSH; Antiviral therapy; HHV6; Infections virales; RSV; Traitement antiviral; VRS; Viral infections